Announcements

Job Offers

Top 5 -yesterday

Top 5 -last week

Top 5 -last month

IL: Company presents a new way of reviewing cannabis genetics

There is a rapid evolution taking place in the cannabis industry. With more and more countries legalizing both medical and recreational use of cannabis, cannabis research, investment, cultivation, and product development are surging. Much of this research focuses around the myriad potential that cannabis may hold for millions suffering from a variety of health complaints around the world. In an effort to make sense of the thousands of cannabis strains available around the world, The Cannigma Tree Ltd. is compiling a comprehensive index, based on lab results, user reports and scientific literature. These reviews present the history and lineage of chemovars (chemical varieties), along with an average chemical profile - that is, the main cannabinoids and terpenes present in the strain. Cannabinoids, like THC and CBD, and terpenes, which are responsible for the aroma of the plant, are the main active compounds in cannabis. 

For patients who need help choosing from the array of cannabis products available in dispensaries today, The Cannigma’s strain pages also suggest medical conditions that the strain may help, along with its sativa/indica classification. 

While the wisdom of the masses holds that indica strains are more sedating and sativa more uplifting, in reality, the effects of a given type of cannabis come down to a variety of factors  — and the chemical makeup is only one of them. A patient’s unique biology, age, and tolerance, as well as the dose and consumption method, also play a part. 

For more information:
Cannigma
cannigma.com  


Publication date:



Receive the daily newsletter in your email for free | Click here


Other news in this sector:


Sign up for our daily Newsletter and stay up to date with all the latest news!

Subscribe I am already a subscriber